Sigma-Aldrich Corp (SIAL) 139.97 $SIAL Epigenet
Post# of 273257
Posted On: 09/03/2016 3:08:51 PM
Sigma-Aldrich Corp (SIAL) 139.97 $SIAL
Epigenetics Market - Global Forecast to 2020 - Increasing Research Activities & High Prevalence of Cancer Driving Growth
M2 - Fri Feb 05, 8:10AM CST
Research and Markets (http://www.researchandmarkets.com/research/cbv3tz/epigenetics) has announced the addition of the "Epigenetics Market - Global Forecast to 2020" report to their offering. The epigenetics market is expected to reach USD 890.0 Million by 2020 from USD 469.6 Million in 2015, at a CAGR of 13.64% between 2015 and 2020. Increasing research activities by academic and research institutes and high prevalence of cancer will majorly drive the growth of the market. Other growth factors include the increasing application for non-oncology diseases; and growing partnership between academic, biotechnology and pharmaceutical companies. The new emerging markets such as Brazil, Russia, India and China will provide opportunities for market growth. In 2015, the North America is expected to command the largest share of the global epigenetics market. Asia is expected to register the highest growth due to high prevalence of cancer, increasing research activities by various research institutes and increasing R & D funding by biotechnology and pharmaceutical companies in this region. Companies Mentioned: - Abcam PLC - Active Motif - Diagenode, Inc. - Illumina, Inc. - Merck & Co., Inc. - New England Biolabs - Qiagen N.V. - Sigma-Aldrich Corporation - Thermo Fisher Scientific, Inc. - Zymo Research Corporation Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Epigenetics Market, By Product 7 Epigenetics Market, By Research Area 8 Epigenetics Market, By Region 9 Competitive Landscape 10 Company Profiles For more information visit http://www.researchandmarkets.com/research/cb...pigenetics
SIAL: 139.97 (+0.21), MRK: 62.98 (+0.08), ILMN: 167.90 (-0.66), QGEN: 26.63 (+0.17)
qPCR Reagents Market by Detection, Packaging, End User & Application - Global Forecasts to 2020
M2 - Wed Jan 20, 5:26AM CST
Research and Markets (http://www.researchandmarkets.com/research/94xqhg/qpcr_reagents) has announced the addition of the "qPCR Reagents Market - Global Forecasts to 2020" report to their offering. Market growth can be attributed to factors such as rising patient population base for infectious diseases & genetic disorders, coupled with growing geriatric population, technological advancements in the life sciences sector, increasing public-private investments, funds, and grants for PCR-based research, and the successful completion of the human genome project. However, technical limitations associated with qPCR are restraining the growth of this market. North America (particularly the U.S.) is expected to hold the largest share of qPCR reagents market during the forecast period. Factors such as high penetration of qPCR technologies among key end users, increasing public & private funding to expand the application base of qPCR, ongoing product advancements in the field of qPCR reagents, and continuous reduction in the average cost of genome sequencing are driving the growth of the North American market. In 2014, Thermo Fisher Scientific (U.S.) dominated the global qPCR reagents market. Over the past three years, the company adopted product commercialization, agreements, collaborations, geographic expansion, and awareness campaigns as key business strategies to maintain its position in the market. Companies Mentioned: - Affymetrix, Inc. - Agilent Technologies, Inc. - Bio-Rad Laboratories, Inc. - F. Hoffman-La Roche Ltd. - Promega Corporation - Qiagen N.V. - Quanta Biosciences, Inc. - Sigma-Aldrich Corporation (A Subsidiary of Merck Kgaa, Germany) - Takara Bio Inc. - Thermo Fisher Scientific Inc. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Trends 7 qPCR Reagents Market, By Detection Method 8 qPCR Reagents Market, By Packaging Type 9 qPCR Reagents Market, By End User 10 qPCR Reagents Market, By Application 11 qPCR Reagents Market, By Region 12 Competitive Landscape 13 Company Profiles For more information visit http://www.researchandmarkets.com/research/94...r_reagents
A: 47.00 (+0.01), SIAL: 139.97 (+0.21), QGEN: 26.63 (+0.17), AFFX: 14.01 (+0.02)
Global Active Pharmaceutical Ingredients (API) Market Worth USD 175 Billion by 2020 - Analysis, Technologies & Forecasts Report 2016-2020 - Key Vendors: Bayer, Mylan & Zoetis
M2 - Thu Jan 14, 5:06AM CST
Research and Markets (http://www.researchandmarkets.com/research/b8kwlw/global_active) has announced the addition of the "Global Active Pharmaceutical Ingredients (API) Market Analysis & Trends - Industry Forecast to 2020" report to their offering. The Global Active Pharmaceutical Ingredients (API) Market is poised to grow at a CAGR of around 6.9% in the next 5 years to reach approximately $175 billion by 2020. This industry report analyzes the global markets for Active Pharmaceutical Ingredients (API) across all the given segments in the research scope. It presents historical market data for 2012, 2013, 2014 revenue estimations are presented for 2015 and forecasts till 2020. The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. The Active Pharmaceutical Ingredients (API) Market report provides 252 data tables, includes charts and graphs for visual analysis. Key Topics Covered: - Market forecasts till 2020, using estimated market values as the base numbers - Key market trends across the business segments, Regions and countries - Key developments and strategies observed in the market - In-depth company profiles of key players and upcoming prominent players - Market opportunities and recommendations for new investments Companies Mentioned: - Aurobindo Pharma Ltd. - Bayer Healthcare (Germany) - Bioniche Animal Health (Canada) - Boehringer Ingelheim (Germany) - Ceva Animal Health, Inc. - Dr. Reddy's Laboratories Ltd. - Elanco Animal Health (U.S.) - Heska Co. (U.S.) - Merck Animal Health (U.S.) - Merial Inc. (Sanofi) (France) - Mylan Inc. - Sigma-Aldrich Corporation - Sun Pharmaceutical Industries Ltd. - Virbac - Zoetis (U.S.) Report Structure: 1 Market Outline 2 Executive Summary 3 Market Overview 4 Global Active Pharmaceutical Ingredients market by Therapeutic applications 5 Global Active Pharmaceutical Ingredients market by type of API 6 Global Active Pharmaceutical Ingredients market by type of manufacturing 7 Global Active Pharmaceutical Ingredients market by Type of Drug 8 Global Active Pharmaceutical Ingredients market by Geography 9 Leading Companies For more information visit http://www.researchandmarkets.com/research/b8...bal_active
SIAL: 139.97 (+0.21), MRK: 62.98 (+0.08)
Global BiopreservationMarket 2015-2020 - A Critical Activity for Improving Human Healthcare - Strategic Business Report
M2 - Mon Jan 11, 3:35AM CST
Research and Markets (http://www.researchandmarkets.com/research/5sjxgc/biopreservation) has announced the addition of the "Biopreservation - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. This report analyzes the worldwide markets for Biopreservation in US$ Million. The Global market is further analyzed by the following Product Segments, Applications, and Biospecimen Type - Product Segments: Equipment, and Media; Applications: R&D, Therapeutic, and Others; Biospecimen Types: Organs, Stem Cells, Tissues, and Others. Annual estimates and forecasts are provided for the period 2013 through 2020. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 82 companies including many key and niche players such as - Atlanta Biologicals, Inc. (USA) - Biocision LLC (USA) - Biogenics Inc. (USA) - Biolife Solutions, Inc. (USA) - Cell & Tissue Systems, Inc. (USA) - Cesca Therapeutics Inc. (USA) - Core Dynamics, Ltd. (Israel) - Custom Biogenic Systems, Inc. (USA) - Essential Pharmaceuticals LLC (USA) - Lifeline Scientific, Inc. (USA) - Panasonic Biomedical Sales Europe B.V. (The Netherlands) - Preservation Solution, Inc. (USA) - Princeton Cryotech, Inc. (USA) - Sigma-Aldrich Corporation (USA) - So-Low Environmental Equipment Co., Inc. (USA) - Taylor-Wharton Cryogenics LLC (USA) - Thermo Fisher Scientific, Inc. (USA) - VWR International LLC (USA) - Wak-Chemie Medical Gmbh (Germany) Key Topics Covered: 1. INDUSTRY OVERVIEW 2. MAJOR GROWTH DRIVERS & MARKET TRENDS 3. PRODUCT OVERVIEW 4. PRODUCT INTRODUCTIONS 5. RECENT INDUSTRY ACTIVITY 6. FOCUS ON SELECT PLAYERS 7. GLOBAL MARKET PERSPECTIVE Total Companies Profiled: 82 - The United States (50) - Canada (1) - Japan (1) - Europe (24) - - France (2) - - Germany (7) - - The United Kingdom (7) - - Italy (1) - - Rest of Europe (7) - Asia-Pacific (Excluding Japan) (4) - Middle East (2) For more information visit http://www.researchandmarkets.com/research/5s...eservation
KOOL: 4.10 (-0.07), SIAL: 139.97 (+0.21)
Oligonucleotide Synthesis Market 2015 by Product & Services, Application, End-User - Market to Grow at a CAGR of 10% with Global Forecasts to 2020
M2 - Thu Dec 17, 3:38AM CST
Research and Markets (http://www.researchandmarkets.com/research/bj4gqt/oligonucleotide) has announced the addition of the "Oligonucleotide Synthesis Market by Product & Services, Application, End-User - Global Forecast to 2020" report to their offering. Major factors driving the growth of this market include increasing R&D expenses in pharmaceutical and biotechnology companies, rising demand for synthesized oligonucleotides due to the growing field of molecular diagnostics, increasing government investments to develop genomic technologies, rising venture capital investments, and increasing demand for synthetic genes. The increasing applications of oligonucleotides in nucleic acid array-based technologies, library preparations, next-generation sequencing (NGS), genomics, nucleic acid-base detections, cell cultures, diagnostics, therapeutics, human identity testing, cloning, genetic engineering, and synthetic biology also play a vital role in the development of this market. In addition, emerging Asian markets and the growing field of NGS have opened an array of opportunities for players in the oligonucleotide synthesis market. However, price erosion and lack of regulations for therapeutic oligonucleotides could hinder the growth of this market. Geographically, North America is expected to dominate the market in 2015, followed by Europe. However, the Asia-Pacific oligonucleotide synthesis market is slated to grow at the highest CAGR owing to the growing availability of synthesized oligos, increase in R&D funding and activities, and increasing focus of prominent players in in the APAC region. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Insights 7 Oligonucleotide Synthesis Market, By Products & Services 8 Oligonucleotide Synthesis Market, By Application 9 Oligonucleotide Synthesis Market, By End User 10 Regional Analysis 11 Competitive Landscape 12 Company Profiles - Agilent Technologies, Inc. - Bioautomation Corporation - Biosearch Technologies, Inc. - Eurofins Genomics - Eurogentec S.A. - Gen9, Inc. - Genedesign, Inc. - General Electric Company (Ge) - Genscript Usa Inc. - Integrated Dna Technologies, Inc. (Idt) - Nitto Denko Avecia Inc. (Avecia) - Sigma-Aldrich Corporation - Thermo Fisher Scientific, Inc. - Trilink Biotechnologies, Inc. For more information visit http://www.researchandmarkets.com/research/bj...nucleotide
GE: 31.29 (+0.09), A: 47.00 (+0.01), SIAL: 139.97 (+0.21)
Biological Safety Testing Market - Expected to Grow at a CAGR of 12.23% to Reach $3,130.85 Million by 2019
M2 - Mon Dec 14, 6:49AM CST
Research and Markets (http://www.researchandmarkets.com/research/w9wm6n/biological_safety) has announced the addition of the "Biological Safety Testing Market by Application, Product & Test - Global Forecast " report to their offering. The global pharmaceutical industry is expected to grow at a CAGR between 5% and 8%. According to the IMS Institute of Healthcare Informatics, the global biologics market has increased from $46 billion in 2002 to $169 billion in 2012. Biologics accounted for 11% of the total sales of drugs in 2002, which increased to 18% in 2012. The biologics safety testing market is growing at a favorable rate. The major drivers for the market include growth of the pharmaceutical and biological industries and an increasing number of new drug launches. It is estimated that this figure will rise to 20% by 2017, with a total market value of $221 billion. According to Ernst & Young's Global Biotechnology Report 2013, companies in biotech centers in the U.S., Europe, Canada, and Australia achieved revenues of about $90 billion in 2012. This was an 8% increase over their revenues in 2011. Owing to the rise in the number of biotechnology companies, biopharmaceutical production has increased globally. Biologics safety testing is carried out at all levels of pharmaceutical and biopharmaceutical manufacturing process to minimize the risk of product contamination. Growth in pharmaceutical and biotechnology industries will drive the growth of the biologics safety testing market. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Insights 7 Biologics Safety Testing Market, By Application 8 Biologics Safety Testing Market, By Product 9 Biologics Safety Testing Market, By Test 10 Biologics Safety Testing Market, By Region 11 Competitive Landscape 12 Company Profiles Companies Mentioned: - Avance Biosciences Inc. - BSL Bioservice - Charles River Laboratories International, Inc. - Cytovance Biologics, Inc. - Lonza Group - Merck & Co., Inc. - SGS S.A. - Sigma-Aldrich Corporation - Toxikon Corporation - Wuxi Pharmatech (Cayman) Inc. For more information visit http://www.researchandmarkets.com/research/w9...cal_safety
SIAL: 139.97 (+0.21), MRK: 62.98 (+0.08), CRL: 84.42 (+0.82)
Asia Chromatography Solvents Market Report - Analysis, Technologies & Forecast 2015-2020
M2 - Mon Dec 14, 5:51AM CST
Research and Markets (http://www.researchandmarkets.com/research/sggtpb/asia) has announced the addition of the "Asia Chromatography Solvents Market - Analysis and Forecast to 2020" report to their offering. The objective of this report is to cover the definition, scope, description, and forecast of the Asian chromatography solvents market. It involves a deep dive analysis of the market segmentation, which is based on solvent type, grade, application and end-user. The report also offers insights into the competitive landscape of the market through a strategic analysis of the key players of the market. The chromatography solvents market, in terms of solvent type has been segmented into polar solvents and non-polar solvents. The market is further segmented based on solvent grade into LCMS Grade, HPLC Grade and UHPLC grade. From application approach, the market is segmented into analytical and preparative chromatography. The major end-users of the market are Pharmaceutical & Biotechnology industry; Academic, Research & Government institutes; Food & Beverage industry; and cosmetics industry. The report also provides a detailed competitive landscaping of companies operating in this market. Segment and country-specific company shares, news & deals, M&As, and segment-specific pipeline products, product approvals, and product recalls, of the major companies have been detailed in the report. Companies Mentioned: - Avantor Performance Materials - EMD Millipore/ Merck Millipore (A Division Of Merck Kgaa) - Qualikems Fine Chem Pvt. Ltd. - Regis Technologies Inc., - Sigma-Aldrich Corporation - Tedia Company, Inc. - Thermo Fisher Scientific - VWR International Report Structure: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Market Overview 5 Asia Chromatography Solvents Market, By Type 6 Asia Chromatography Solvents Market, By Grade 7 Asia Chromatography Solvents Market, By Application 8 Asia Chromatography Solvents Market, By End User 9 Asia Chromatography Solvents Market, By Geography 10 Asia Chromatography Solvents Market: Competive Landscape 11 Asia Chromatography Solvents Market, By Company 12 Appendix For more information visit http://www.researchandmarkets.com/research/sggtpb/asia
SIAL: 139.97 (+0.21), MRK: 62.98 (+0.08)
The Global Biopreservation Market is Expected to Reach USD 3,731.03 Million by 2020 - Report
M2 - Tue Dec 08, 8:40AM CST
Research and Markets (http://www.researchandmarkets.com/research/g26dfb/biopreservation) has announced the addition of the "Biopreservation Market - Global Forecast to 2020" report to their offering. There are a number of key factors driving growth in the Global Biopreservation Market. This new report lists a growing demand for preserving new-born stem cells, increasing R&D spending on research, increasing healthcare and expenditure and an increasing demand for regenerative medicine as major drivers fro the market. It does go on to state that the high cost of technologically advanced products and stability issues of specimens acts as a restraint for new entrant in the market. The market is expected to reach $3,731.03 million by 2020 from $2,150.48 million in 2015. The therapeutic applications had the largest share of the biopreservation media and equipment market in 2015 and this is expected to be a continuous trend, with the report predicting that it would be one of the fastest growing applications between 2015 and 2020. The geographic analysis reveals that North America accounted for the largest share in the global biopreservation media & equipment market in 2015. Asia regional segment, on the other hand, is expected to register a faster growth from 2015 to 2020, due to the increasing population and healthcare spending from this region. Companies Mentioned in the report: - Biocision, Llc - Biolife Solutions, Inc. - Cesca Therapeutics Inc. - Core Dynamics, Ltd. - Custom Biogenic Systems, Inc. - Lifeline Scientific, Inc. - Princeton Cryotech, Inc. - Sigma-Aldrich Corporation - So-Low Environmental Equipment Co., Inc. - Thermo Fisher Scientific, Inc. - VWR Corporation Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Biopreservation Media & Equipment Market, By Product 7 Biopreservation Media & Equipment Market, By Biospecimen 8 Biopreservation Media & Equipment Market, By Application 9 Biopreservation Media & Equipment Market, By End User 10 Biopreservation Media & Equipment Market, By Region 11 Competitive Landscape 12 Company Profiles For more information visit http://www.researchandmarkets.com/research/g2...eservation
KOOL: 4.10 (-0.07), VWR: 27.79 (+0.04), SIAL: 139.97 (+0.21)
Tissue Diagnostics Market by Technology, Product, and End Users & Region - Global Forecast to 2020
M2 - Tue Dec 08, 3:13AM CST
Research and Markets (http://www.researchandmarkets.com/research/9ckzgm/tissue) has announced the addition of the "Tissue Diagnostics Market - Global Forecast to 2020" report to their offering. The global tissue diagnostics market is valued at USD 3,202.5 million in 2015 and expected to reach USD 4,471.1 million by 2020, at a CAGR of 6.9% from 2015 to 2020. The geographic analysis reveals that North America accounted for the largest share in the global tissue diagnostics market in 2015. Asia, on the other hand, is expected to register faster growth during 2015 to 2020. The key drivers for this market are the increasing prevalence of cancer, growing geriatric population, and growing healthcare expenditure. On the other hand, the high degree of consolidation, stringent regulatory requirements, and lack of budgets are restraining the growth of this market. The report provides qualitative insights about key market shares, growth rates, and market drivers for all important subsegments. It maps the market sizes and growth rates of each subsegment and identifies the segments expected to see rapid growth in each geographic segment. The report also includes company profiles of market leaders. These company profiles include financial performances, product portfolios, and market developments for each company. The report also provides a competitive landscape of the tissue diagnostics market. The competitive landscape covers the growth strategies adopted by industry players over the last four years. It also includes an analysis of industry developments. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Tissue Diagnostics Market, By Product 7 Tissue Diagnostics Market, By Diseases 8 Tissue Diagnostics Market, By Technology 9 Tissue Diagnostics Market, By End User 10 Tissue Diagnostics Market, By Region 11 Competitive Landscape 12 Company Profiles - Abbott Laboratories, Inc. - Agilent Technologies, Inc. - Bio SB - Biogenex Laboratories - Cell Signaling Technology, Inc. - Danaher Corporation - F. Hoffman-La Roche AG - Sakura Finetek Japan Co., Ltd. - Sigma-Aldrich Corporation - Thermo Fisher Scientific For more information visit http://www.researchandmarkets.com/research/9ckzgm/tissue
ABT: 42.09 (-0.21), A: 47.00 (+0.01), SIAL: 139.97 (+0.21), DHR: 81.19 (-0.25)
Tetrahydrofuran (THF): PTMEG Poly Tetra Methylene Ether Glycol, and Solvent - Global Strategic Business Report 2015-2020
M2 - Mon Dec 07, 8:53AM CST
Research and Markets (http://www.researchandmarkets.com/research/zxrdf8/tetrahydrofuran) has announced the addition of the "Tetrahydrofuran (THF) - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. This report analyzes the worldwide markets for Tetrahydrofuran (THF) in Metric Tons by the following End-Use Segments: PTMEG Poly Tetra Methylene Ether Glycol, and Solvent. The report profiles 31 companies including many key and niche players such as - Ashland, Inc. (US) - BASF SE (Germany) - BioAmber, Inc. (Canada) - Dairen Chemical Corporation (China) - Invista (US) - Mitsubishi Chemical Corporation (Japan) - Penn A Kem LLC (US) - Saudi International Petrochemical Company (Saudi Arabia) - Shanxi Sanwei Group Co., Ltd. (China) - Sigma-Aldrich Corp. (US) - Sinochem International Corporation (China) - TCC Chemical Corporation (Taiwan) - Zibo Linzi Bingqing Fine Chemical Factory (China) Key Topics Covered: 1. INDUSTRY OVERVIEW 2. MARKET TRENDS, ISSUES & DRIVERS 3. PRODUCT OVERVIEW 4. RECENT INDUSTRY ACTIVITY 5. FOCUS ON SELECT GLOBAL PLAYERS 6. GLOBAL MARKET PERSPECTIVE Total Companies Profiled: 31 (including Divisions/Subsidiaries - 35) - The United States (7) - Canada (1) - Japan (2) - Europe (9) - - Germany (4) - - The United Kingdom (3) - - Rest of Europe (2) - Asia-Pacific (Excluding Japan) (15) - Middle East (1) For more information visit http://www.researchandmarkets.com/research/zx...hydrofuran
ASH: 118.33 (+0.71), SIAL: 139.97 (+0.21), BIOA: 4.03 (+0.13)
Uptrend Call Working As Sigma-Aldrich Stock Rises 47.1% (SIAL)
Comtex SmarTrend(R) - Fri Nov 27, 9:23AM CST
SmarTrend identified an Uptrend for Sigma-Aldrich (NASDAQ:SIAL) on April 2nd, 2014 at $95.00. In approximately 20 months, Sigma-Aldrich has returned 47.12% as of today's recent price of $139.76.
SIAL: 139.97 (+0.21)
Tekna Signs Agreement with Sigma-Aldrich for Worldwide Distribution of its Nanoparticles in Sample Quantities
CNW Group - Thu Nov 19, 7:55AM CST
Tekna has entered into an Agreement with Sigma-Aldrich Corporation (SIAL, NASDAQ). The terms of the Agreement enable Sigma-Aldrich to distribute sample size quantities of Tekna's famous Boron Nitride NanoTubes (BNNTs), copper nanoparticles and silicon nanoparticles throughout Sigma-Aldrich's worldwide sales and distribution network.
SIAL: 139.97 (+0.21)
Global Proteomics Market 2015-2021 - Company Profiles, Share, Trends, Analysis, Opportunities, Segmentation and Forecasts
M2 - Fri Nov 13, 3:52AM CST
Research and Markets (http://www.researchandmarkets.com/research/7fd5rf/global_proteomics) has announced the addition of the "Global Proteomics Market by Country (United States, Canada, India, China, Japan, United Kingdom), Company Profiles, Share, Trends, Analysis, Opportunities, Segmentation and Forecast 2015 - 2021" report to their offering. Proteomics market is expected to grow impressively with approximate compounded annual growth rate of 20% for the forecasted period of 2015-2021. The proteomics market is segmented on the basis of proteomics instrumentation technology such as protein micro array (biochips, micro array instruments), spectroscopy (Mass and NMR), X-ray crystallography, chromatography, electrophoresis, proteomics reagents, proteomics services (analytical lab services, protein identification, extraction, sequencing, data analysis, maintaining bioinformatics data bases). The market is driven by growing need of personalized medicines, new discoveries in the field of genomics, rise in funds for proteomics based research, growing research and development expenditure, advancement in technologies, new techniques, high output, high resolutions achiness and instruments have been developed, availability of private funds and rise in the Asian markets like China and Japan. . The top 10 companies own 40 to 50 percent of the market. Proteomic instrumentation market is dominated by proteomic microarray, accounting for around 50% of the revenue followed by spectroscopy techniques. Proteomic reagents market is dominated by immunoassays. The market is restrained by various factors such as: success ratio of the researches is not very high, limitations of personalized medicines and lengthy regulatory approval process, reduction in funds by the US government, which owes 40% of this market, highly expensive medicines, which are 1000 fold costlier than the normal medicines present in the market and research and market is limited to a few developed nations only. Major opportunities for the market lie in the Asian markets where contract research organizations are on a rise. Proteomics is science with broad applications in the field of therapeutics and diagnostics. Growing R&D and emergence of new players will create more market opportunities. Major players in the proteomics market are Thermo Fischer scientific corporation, Agilent technologies, Luminex corporation, Sigma-Aldrich corporation, Danaher corporation, Bio-Rad corporation, Waters corporation, PerkinElmer, Affymetrix and others. Key Topics Covered: 1. Introduction 2. Market overview 3. Market determinants 4. Sector Analysis 5. Market Segmentation 6. Competitive Landscape 7. Geographical analysis 8. Company Profiles - Activx Biosciences Inc - Affymetrix - Agilent technologies - Amgen Inc - Anaspec Inc - Applied biosystems Inc - Asterand PLC - Bayer technology - Beckman coulter - Becton Dickinson and Co - BG medicine - Biacore International AB - Biocarta Inc - Bio-Rad corporation - Bruker biosciences - Caliper Lifesciences - Cellzome AG - Commonwealth biotechnologies - Danaher corporation - Digilab biovision GmBH - Dionex Corp - Dualsystems biotech AG - GE healthcare - Genesystems Inc - Genzyme Corporation - Luminex corporation - PerkinElmer - Sigma-Aldrich corporation - Thermo Fischer scientific corporation - Waters corporation For more information visit http://www.researchandmarkets.com/research/7f...proteomics
SIAL: 139.97 (+0.21), AMGN: 169.77 (-0.36), LMNX: 21.12 (+0.19), DHR: 81.19 (-0.25), BCOR: 10.72 (+0.26), PKI: 53.46 (+0.20), WAT: 156.19 (+0.09)
Illumina Set to Join the S&P 500
PR Newswire - Thu Nov 12, 5:44PM CST
Illumina Inc. (NASD:ILMN) will replace Sigma-Aldrich Corp. (NASD:SIAL) in the S&P 500 after the close of trading on Wednesday, November 18. Merck KGaA is acquiring Sigma-Aldrich in a deal expected to be completed on or about that date pending final conditions.
SIAL: 139.97 (+0.21), ILMN: 167.90 (-0.66), MHFI: 107.92 (+1.16)
Sigma-Aldrich's Buyout by Merck KGaA Gets Final EC Approval
Zacks Equity Research - Zacks Investment Research - Thu Nov 12, 11:00AM CST
Sigma-Aldrich (SIAL) has obtained the final clearance from the European Commission (???EC???) for its proposed acquisition Merck KGaA.
CE: 64.59 (+0.84), SIAL: 139.97 (+0.21), AVD: 16.75 (+0.18), CHMT: 30.27 (-0.03)
Sigma-Aldrich and Merck KGaA, Darmstadt, Germany, Obtain EC Antitrust Approval and Work Toward Closing Planned Acquisition
PR Newswire - Tue Nov 10, 10:52AM CST
Sigma-Aldrich Corporation (NASDAQ: SIAL) today announced it has secured final approval from the European Commission (EC) on the planned acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany.
HON: 116.39 (+0.26), SIAL: 139.97 (+0.21)
Sigma-Aldrich Shares Up 46.9% Since SmarTrend's Buy Recommendation (SIAL)
Comtex SmarTrend(R) - Thu Nov 05, 10:35AM CST
SmarTrend identified an Uptrend for Sigma-Aldrich (NASDAQ:SIAL) on April 2nd, 2014 at $95.00. In approximately 19 months, Sigma-Aldrich has returned 46.93% as of today's recent price of $139.58.
SIAL: 139.97 (+0.21)
47.0% Return Seen to Date on SmarTrend Sigma-Aldrich Call (SIAL)
Comtex SmarTrend(R) - Thu Nov 05, 10:31AM CST
SmarTrend identified an Uptrend for Sigma-Aldrich (NASDAQ:SIAL) on April 2nd, 2014 at $95.00. In approximately 19 months, Sigma-Aldrich has returned 46.97% as of today's recent price of $139.62.
SIAL: 139.97 (+0.21)
Epigenetics Market - Global Forecast to 2020 - Increasing Research Activities & High Prevalence of Cancer Driving Growth
M2 - Fri Feb 05, 8:10AM CST
Research and Markets (http://www.researchandmarkets.com/research/cbv3tz/epigenetics) has announced the addition of the "Epigenetics Market - Global Forecast to 2020" report to their offering. The epigenetics market is expected to reach USD 890.0 Million by 2020 from USD 469.6 Million in 2015, at a CAGR of 13.64% between 2015 and 2020. Increasing research activities by academic and research institutes and high prevalence of cancer will majorly drive the growth of the market. Other growth factors include the increasing application for non-oncology diseases; and growing partnership between academic, biotechnology and pharmaceutical companies. The new emerging markets such as Brazil, Russia, India and China will provide opportunities for market growth. In 2015, the North America is expected to command the largest share of the global epigenetics market. Asia is expected to register the highest growth due to high prevalence of cancer, increasing research activities by various research institutes and increasing R & D funding by biotechnology and pharmaceutical companies in this region. Companies Mentioned: - Abcam PLC - Active Motif - Diagenode, Inc. - Illumina, Inc. - Merck & Co., Inc. - New England Biolabs - Qiagen N.V. - Sigma-Aldrich Corporation - Thermo Fisher Scientific, Inc. - Zymo Research Corporation Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Epigenetics Market, By Product 7 Epigenetics Market, By Research Area 8 Epigenetics Market, By Region 9 Competitive Landscape 10 Company Profiles For more information visit http://www.researchandmarkets.com/research/cb...pigenetics
SIAL: 139.97 (+0.21), MRK: 62.98 (+0.08), ILMN: 167.90 (-0.66), QGEN: 26.63 (+0.17)
qPCR Reagents Market by Detection, Packaging, End User & Application - Global Forecasts to 2020
M2 - Wed Jan 20, 5:26AM CST
Research and Markets (http://www.researchandmarkets.com/research/94xqhg/qpcr_reagents) has announced the addition of the "qPCR Reagents Market - Global Forecasts to 2020" report to their offering. Market growth can be attributed to factors such as rising patient population base for infectious diseases & genetic disorders, coupled with growing geriatric population, technological advancements in the life sciences sector, increasing public-private investments, funds, and grants for PCR-based research, and the successful completion of the human genome project. However, technical limitations associated with qPCR are restraining the growth of this market. North America (particularly the U.S.) is expected to hold the largest share of qPCR reagents market during the forecast period. Factors such as high penetration of qPCR technologies among key end users, increasing public & private funding to expand the application base of qPCR, ongoing product advancements in the field of qPCR reagents, and continuous reduction in the average cost of genome sequencing are driving the growth of the North American market. In 2014, Thermo Fisher Scientific (U.S.) dominated the global qPCR reagents market. Over the past three years, the company adopted product commercialization, agreements, collaborations, geographic expansion, and awareness campaigns as key business strategies to maintain its position in the market. Companies Mentioned: - Affymetrix, Inc. - Agilent Technologies, Inc. - Bio-Rad Laboratories, Inc. - F. Hoffman-La Roche Ltd. - Promega Corporation - Qiagen N.V. - Quanta Biosciences, Inc. - Sigma-Aldrich Corporation (A Subsidiary of Merck Kgaa, Germany) - Takara Bio Inc. - Thermo Fisher Scientific Inc. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Trends 7 qPCR Reagents Market, By Detection Method 8 qPCR Reagents Market, By Packaging Type 9 qPCR Reagents Market, By End User 10 qPCR Reagents Market, By Application 11 qPCR Reagents Market, By Region 12 Competitive Landscape 13 Company Profiles For more information visit http://www.researchandmarkets.com/research/94...r_reagents
A: 47.00 (+0.01), SIAL: 139.97 (+0.21), QGEN: 26.63 (+0.17), AFFX: 14.01 (+0.02)
Global Active Pharmaceutical Ingredients (API) Market Worth USD 175 Billion by 2020 - Analysis, Technologies & Forecasts Report 2016-2020 - Key Vendors: Bayer, Mylan & Zoetis
M2 - Thu Jan 14, 5:06AM CST
Research and Markets (http://www.researchandmarkets.com/research/b8kwlw/global_active) has announced the addition of the "Global Active Pharmaceutical Ingredients (API) Market Analysis & Trends - Industry Forecast to 2020" report to their offering. The Global Active Pharmaceutical Ingredients (API) Market is poised to grow at a CAGR of around 6.9% in the next 5 years to reach approximately $175 billion by 2020. This industry report analyzes the global markets for Active Pharmaceutical Ingredients (API) across all the given segments in the research scope. It presents historical market data for 2012, 2013, 2014 revenue estimations are presented for 2015 and forecasts till 2020. The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. The Active Pharmaceutical Ingredients (API) Market report provides 252 data tables, includes charts and graphs for visual analysis. Key Topics Covered: - Market forecasts till 2020, using estimated market values as the base numbers - Key market trends across the business segments, Regions and countries - Key developments and strategies observed in the market - In-depth company profiles of key players and upcoming prominent players - Market opportunities and recommendations for new investments Companies Mentioned: - Aurobindo Pharma Ltd. - Bayer Healthcare (Germany) - Bioniche Animal Health (Canada) - Boehringer Ingelheim (Germany) - Ceva Animal Health, Inc. - Dr. Reddy's Laboratories Ltd. - Elanco Animal Health (U.S.) - Heska Co. (U.S.) - Merck Animal Health (U.S.) - Merial Inc. (Sanofi) (France) - Mylan Inc. - Sigma-Aldrich Corporation - Sun Pharmaceutical Industries Ltd. - Virbac - Zoetis (U.S.) Report Structure: 1 Market Outline 2 Executive Summary 3 Market Overview 4 Global Active Pharmaceutical Ingredients market by Therapeutic applications 5 Global Active Pharmaceutical Ingredients market by type of API 6 Global Active Pharmaceutical Ingredients market by type of manufacturing 7 Global Active Pharmaceutical Ingredients market by Type of Drug 8 Global Active Pharmaceutical Ingredients market by Geography 9 Leading Companies For more information visit http://www.researchandmarkets.com/research/b8...bal_active
SIAL: 139.97 (+0.21), MRK: 62.98 (+0.08)
Global BiopreservationMarket 2015-2020 - A Critical Activity for Improving Human Healthcare - Strategic Business Report
M2 - Mon Jan 11, 3:35AM CST
Research and Markets (http://www.researchandmarkets.com/research/5sjxgc/biopreservation) has announced the addition of the "Biopreservation - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. This report analyzes the worldwide markets for Biopreservation in US$ Million. The Global market is further analyzed by the following Product Segments, Applications, and Biospecimen Type - Product Segments: Equipment, and Media; Applications: R&D, Therapeutic, and Others; Biospecimen Types: Organs, Stem Cells, Tissues, and Others. Annual estimates and forecasts are provided for the period 2013 through 2020. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 82 companies including many key and niche players such as - Atlanta Biologicals, Inc. (USA) - Biocision LLC (USA) - Biogenics Inc. (USA) - Biolife Solutions, Inc. (USA) - Cell & Tissue Systems, Inc. (USA) - Cesca Therapeutics Inc. (USA) - Core Dynamics, Ltd. (Israel) - Custom Biogenic Systems, Inc. (USA) - Essential Pharmaceuticals LLC (USA) - Lifeline Scientific, Inc. (USA) - Panasonic Biomedical Sales Europe B.V. (The Netherlands) - Preservation Solution, Inc. (USA) - Princeton Cryotech, Inc. (USA) - Sigma-Aldrich Corporation (USA) - So-Low Environmental Equipment Co., Inc. (USA) - Taylor-Wharton Cryogenics LLC (USA) - Thermo Fisher Scientific, Inc. (USA) - VWR International LLC (USA) - Wak-Chemie Medical Gmbh (Germany) Key Topics Covered: 1. INDUSTRY OVERVIEW 2. MAJOR GROWTH DRIVERS & MARKET TRENDS 3. PRODUCT OVERVIEW 4. PRODUCT INTRODUCTIONS 5. RECENT INDUSTRY ACTIVITY 6. FOCUS ON SELECT PLAYERS 7. GLOBAL MARKET PERSPECTIVE Total Companies Profiled: 82 - The United States (50) - Canada (1) - Japan (1) - Europe (24) - - France (2) - - Germany (7) - - The United Kingdom (7) - - Italy (1) - - Rest of Europe (7) - Asia-Pacific (Excluding Japan) (4) - Middle East (2) For more information visit http://www.researchandmarkets.com/research/5s...eservation
KOOL: 4.10 (-0.07), SIAL: 139.97 (+0.21)
Oligonucleotide Synthesis Market 2015 by Product & Services, Application, End-User - Market to Grow at a CAGR of 10% with Global Forecasts to 2020
M2 - Thu Dec 17, 3:38AM CST
Research and Markets (http://www.researchandmarkets.com/research/bj4gqt/oligonucleotide) has announced the addition of the "Oligonucleotide Synthesis Market by Product & Services, Application, End-User - Global Forecast to 2020" report to their offering. Major factors driving the growth of this market include increasing R&D expenses in pharmaceutical and biotechnology companies, rising demand for synthesized oligonucleotides due to the growing field of molecular diagnostics, increasing government investments to develop genomic technologies, rising venture capital investments, and increasing demand for synthetic genes. The increasing applications of oligonucleotides in nucleic acid array-based technologies, library preparations, next-generation sequencing (NGS), genomics, nucleic acid-base detections, cell cultures, diagnostics, therapeutics, human identity testing, cloning, genetic engineering, and synthetic biology also play a vital role in the development of this market. In addition, emerging Asian markets and the growing field of NGS have opened an array of opportunities for players in the oligonucleotide synthesis market. However, price erosion and lack of regulations for therapeutic oligonucleotides could hinder the growth of this market. Geographically, North America is expected to dominate the market in 2015, followed by Europe. However, the Asia-Pacific oligonucleotide synthesis market is slated to grow at the highest CAGR owing to the growing availability of synthesized oligos, increase in R&D funding and activities, and increasing focus of prominent players in in the APAC region. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Insights 7 Oligonucleotide Synthesis Market, By Products & Services 8 Oligonucleotide Synthesis Market, By Application 9 Oligonucleotide Synthesis Market, By End User 10 Regional Analysis 11 Competitive Landscape 12 Company Profiles - Agilent Technologies, Inc. - Bioautomation Corporation - Biosearch Technologies, Inc. - Eurofins Genomics - Eurogentec S.A. - Gen9, Inc. - Genedesign, Inc. - General Electric Company (Ge) - Genscript Usa Inc. - Integrated Dna Technologies, Inc. (Idt) - Nitto Denko Avecia Inc. (Avecia) - Sigma-Aldrich Corporation - Thermo Fisher Scientific, Inc. - Trilink Biotechnologies, Inc. For more information visit http://www.researchandmarkets.com/research/bj...nucleotide
GE: 31.29 (+0.09), A: 47.00 (+0.01), SIAL: 139.97 (+0.21)
Biological Safety Testing Market - Expected to Grow at a CAGR of 12.23% to Reach $3,130.85 Million by 2019
M2 - Mon Dec 14, 6:49AM CST
Research and Markets (http://www.researchandmarkets.com/research/w9wm6n/biological_safety) has announced the addition of the "Biological Safety Testing Market by Application, Product & Test - Global Forecast " report to their offering. The global pharmaceutical industry is expected to grow at a CAGR between 5% and 8%. According to the IMS Institute of Healthcare Informatics, the global biologics market has increased from $46 billion in 2002 to $169 billion in 2012. Biologics accounted for 11% of the total sales of drugs in 2002, which increased to 18% in 2012. The biologics safety testing market is growing at a favorable rate. The major drivers for the market include growth of the pharmaceutical and biological industries and an increasing number of new drug launches. It is estimated that this figure will rise to 20% by 2017, with a total market value of $221 billion. According to Ernst & Young's Global Biotechnology Report 2013, companies in biotech centers in the U.S., Europe, Canada, and Australia achieved revenues of about $90 billion in 2012. This was an 8% increase over their revenues in 2011. Owing to the rise in the number of biotechnology companies, biopharmaceutical production has increased globally. Biologics safety testing is carried out at all levels of pharmaceutical and biopharmaceutical manufacturing process to minimize the risk of product contamination. Growth in pharmaceutical and biotechnology industries will drive the growth of the biologics safety testing market. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Insights 7 Biologics Safety Testing Market, By Application 8 Biologics Safety Testing Market, By Product 9 Biologics Safety Testing Market, By Test 10 Biologics Safety Testing Market, By Region 11 Competitive Landscape 12 Company Profiles Companies Mentioned: - Avance Biosciences Inc. - BSL Bioservice - Charles River Laboratories International, Inc. - Cytovance Biologics, Inc. - Lonza Group - Merck & Co., Inc. - SGS S.A. - Sigma-Aldrich Corporation - Toxikon Corporation - Wuxi Pharmatech (Cayman) Inc. For more information visit http://www.researchandmarkets.com/research/w9...cal_safety
SIAL: 139.97 (+0.21), MRK: 62.98 (+0.08), CRL: 84.42 (+0.82)
Asia Chromatography Solvents Market Report - Analysis, Technologies & Forecast 2015-2020
M2 - Mon Dec 14, 5:51AM CST
Research and Markets (http://www.researchandmarkets.com/research/sggtpb/asia) has announced the addition of the "Asia Chromatography Solvents Market - Analysis and Forecast to 2020" report to their offering. The objective of this report is to cover the definition, scope, description, and forecast of the Asian chromatography solvents market. It involves a deep dive analysis of the market segmentation, which is based on solvent type, grade, application and end-user. The report also offers insights into the competitive landscape of the market through a strategic analysis of the key players of the market. The chromatography solvents market, in terms of solvent type has been segmented into polar solvents and non-polar solvents. The market is further segmented based on solvent grade into LCMS Grade, HPLC Grade and UHPLC grade. From application approach, the market is segmented into analytical and preparative chromatography. The major end-users of the market are Pharmaceutical & Biotechnology industry; Academic, Research & Government institutes; Food & Beverage industry; and cosmetics industry. The report also provides a detailed competitive landscaping of companies operating in this market. Segment and country-specific company shares, news & deals, M&As, and segment-specific pipeline products, product approvals, and product recalls, of the major companies have been detailed in the report. Companies Mentioned: - Avantor Performance Materials - EMD Millipore/ Merck Millipore (A Division Of Merck Kgaa) - Qualikems Fine Chem Pvt. Ltd. - Regis Technologies Inc., - Sigma-Aldrich Corporation - Tedia Company, Inc. - Thermo Fisher Scientific - VWR International Report Structure: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Market Overview 5 Asia Chromatography Solvents Market, By Type 6 Asia Chromatography Solvents Market, By Grade 7 Asia Chromatography Solvents Market, By Application 8 Asia Chromatography Solvents Market, By End User 9 Asia Chromatography Solvents Market, By Geography 10 Asia Chromatography Solvents Market: Competive Landscape 11 Asia Chromatography Solvents Market, By Company 12 Appendix For more information visit http://www.researchandmarkets.com/research/sggtpb/asia
SIAL: 139.97 (+0.21), MRK: 62.98 (+0.08)
The Global Biopreservation Market is Expected to Reach USD 3,731.03 Million by 2020 - Report
M2 - Tue Dec 08, 8:40AM CST
Research and Markets (http://www.researchandmarkets.com/research/g26dfb/biopreservation) has announced the addition of the "Biopreservation Market - Global Forecast to 2020" report to their offering. There are a number of key factors driving growth in the Global Biopreservation Market. This new report lists a growing demand for preserving new-born stem cells, increasing R&D spending on research, increasing healthcare and expenditure and an increasing demand for regenerative medicine as major drivers fro the market. It does go on to state that the high cost of technologically advanced products and stability issues of specimens acts as a restraint for new entrant in the market. The market is expected to reach $3,731.03 million by 2020 from $2,150.48 million in 2015. The therapeutic applications had the largest share of the biopreservation media and equipment market in 2015 and this is expected to be a continuous trend, with the report predicting that it would be one of the fastest growing applications between 2015 and 2020. The geographic analysis reveals that North America accounted for the largest share in the global biopreservation media & equipment market in 2015. Asia regional segment, on the other hand, is expected to register a faster growth from 2015 to 2020, due to the increasing population and healthcare spending from this region. Companies Mentioned in the report: - Biocision, Llc - Biolife Solutions, Inc. - Cesca Therapeutics Inc. - Core Dynamics, Ltd. - Custom Biogenic Systems, Inc. - Lifeline Scientific, Inc. - Princeton Cryotech, Inc. - Sigma-Aldrich Corporation - So-Low Environmental Equipment Co., Inc. - Thermo Fisher Scientific, Inc. - VWR Corporation Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Biopreservation Media & Equipment Market, By Product 7 Biopreservation Media & Equipment Market, By Biospecimen 8 Biopreservation Media & Equipment Market, By Application 9 Biopreservation Media & Equipment Market, By End User 10 Biopreservation Media & Equipment Market, By Region 11 Competitive Landscape 12 Company Profiles For more information visit http://www.researchandmarkets.com/research/g2...eservation
KOOL: 4.10 (-0.07), VWR: 27.79 (+0.04), SIAL: 139.97 (+0.21)
Tissue Diagnostics Market by Technology, Product, and End Users & Region - Global Forecast to 2020
M2 - Tue Dec 08, 3:13AM CST
Research and Markets (http://www.researchandmarkets.com/research/9ckzgm/tissue) has announced the addition of the "Tissue Diagnostics Market - Global Forecast to 2020" report to their offering. The global tissue diagnostics market is valued at USD 3,202.5 million in 2015 and expected to reach USD 4,471.1 million by 2020, at a CAGR of 6.9% from 2015 to 2020. The geographic analysis reveals that North America accounted for the largest share in the global tissue diagnostics market in 2015. Asia, on the other hand, is expected to register faster growth during 2015 to 2020. The key drivers for this market are the increasing prevalence of cancer, growing geriatric population, and growing healthcare expenditure. On the other hand, the high degree of consolidation, stringent regulatory requirements, and lack of budgets are restraining the growth of this market. The report provides qualitative insights about key market shares, growth rates, and market drivers for all important subsegments. It maps the market sizes and growth rates of each subsegment and identifies the segments expected to see rapid growth in each geographic segment. The report also includes company profiles of market leaders. These company profiles include financial performances, product portfolios, and market developments for each company. The report also provides a competitive landscape of the tissue diagnostics market. The competitive landscape covers the growth strategies adopted by industry players over the last four years. It also includes an analysis of industry developments. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Tissue Diagnostics Market, By Product 7 Tissue Diagnostics Market, By Diseases 8 Tissue Diagnostics Market, By Technology 9 Tissue Diagnostics Market, By End User 10 Tissue Diagnostics Market, By Region 11 Competitive Landscape 12 Company Profiles - Abbott Laboratories, Inc. - Agilent Technologies, Inc. - Bio SB - Biogenex Laboratories - Cell Signaling Technology, Inc. - Danaher Corporation - F. Hoffman-La Roche AG - Sakura Finetek Japan Co., Ltd. - Sigma-Aldrich Corporation - Thermo Fisher Scientific For more information visit http://www.researchandmarkets.com/research/9ckzgm/tissue
ABT: 42.09 (-0.21), A: 47.00 (+0.01), SIAL: 139.97 (+0.21), DHR: 81.19 (-0.25)
Tetrahydrofuran (THF): PTMEG Poly Tetra Methylene Ether Glycol, and Solvent - Global Strategic Business Report 2015-2020
M2 - Mon Dec 07, 8:53AM CST
Research and Markets (http://www.researchandmarkets.com/research/zxrdf8/tetrahydrofuran) has announced the addition of the "Tetrahydrofuran (THF) - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. This report analyzes the worldwide markets for Tetrahydrofuran (THF) in Metric Tons by the following End-Use Segments: PTMEG Poly Tetra Methylene Ether Glycol, and Solvent. The report profiles 31 companies including many key and niche players such as - Ashland, Inc. (US) - BASF SE (Germany) - BioAmber, Inc. (Canada) - Dairen Chemical Corporation (China) - Invista (US) - Mitsubishi Chemical Corporation (Japan) - Penn A Kem LLC (US) - Saudi International Petrochemical Company (Saudi Arabia) - Shanxi Sanwei Group Co., Ltd. (China) - Sigma-Aldrich Corp. (US) - Sinochem International Corporation (China) - TCC Chemical Corporation (Taiwan) - Zibo Linzi Bingqing Fine Chemical Factory (China) Key Topics Covered: 1. INDUSTRY OVERVIEW 2. MARKET TRENDS, ISSUES & DRIVERS 3. PRODUCT OVERVIEW 4. RECENT INDUSTRY ACTIVITY 5. FOCUS ON SELECT GLOBAL PLAYERS 6. GLOBAL MARKET PERSPECTIVE Total Companies Profiled: 31 (including Divisions/Subsidiaries - 35) - The United States (7) - Canada (1) - Japan (2) - Europe (9) - - Germany (4) - - The United Kingdom (3) - - Rest of Europe (2) - Asia-Pacific (Excluding Japan) (15) - Middle East (1) For more information visit http://www.researchandmarkets.com/research/zx...hydrofuran
ASH: 118.33 (+0.71), SIAL: 139.97 (+0.21), BIOA: 4.03 (+0.13)
Uptrend Call Working As Sigma-Aldrich Stock Rises 47.1% (SIAL)
Comtex SmarTrend(R) - Fri Nov 27, 9:23AM CST
SmarTrend identified an Uptrend for Sigma-Aldrich (NASDAQ:SIAL) on April 2nd, 2014 at $95.00. In approximately 20 months, Sigma-Aldrich has returned 47.12% as of today's recent price of $139.76.
SIAL: 139.97 (+0.21)
Tekna Signs Agreement with Sigma-Aldrich for Worldwide Distribution of its Nanoparticles in Sample Quantities
CNW Group - Thu Nov 19, 7:55AM CST
Tekna has entered into an Agreement with Sigma-Aldrich Corporation (SIAL, NASDAQ). The terms of the Agreement enable Sigma-Aldrich to distribute sample size quantities of Tekna's famous Boron Nitride NanoTubes (BNNTs), copper nanoparticles and silicon nanoparticles throughout Sigma-Aldrich's worldwide sales and distribution network.
SIAL: 139.97 (+0.21)
Global Proteomics Market 2015-2021 - Company Profiles, Share, Trends, Analysis, Opportunities, Segmentation and Forecasts
M2 - Fri Nov 13, 3:52AM CST
Research and Markets (http://www.researchandmarkets.com/research/7fd5rf/global_proteomics) has announced the addition of the "Global Proteomics Market by Country (United States, Canada, India, China, Japan, United Kingdom), Company Profiles, Share, Trends, Analysis, Opportunities, Segmentation and Forecast 2015 - 2021" report to their offering. Proteomics market is expected to grow impressively with approximate compounded annual growth rate of 20% for the forecasted period of 2015-2021. The proteomics market is segmented on the basis of proteomics instrumentation technology such as protein micro array (biochips, micro array instruments), spectroscopy (Mass and NMR), X-ray crystallography, chromatography, electrophoresis, proteomics reagents, proteomics services (analytical lab services, protein identification, extraction, sequencing, data analysis, maintaining bioinformatics data bases). The market is driven by growing need of personalized medicines, new discoveries in the field of genomics, rise in funds for proteomics based research, growing research and development expenditure, advancement in technologies, new techniques, high output, high resolutions achiness and instruments have been developed, availability of private funds and rise in the Asian markets like China and Japan. . The top 10 companies own 40 to 50 percent of the market. Proteomic instrumentation market is dominated by proteomic microarray, accounting for around 50% of the revenue followed by spectroscopy techniques. Proteomic reagents market is dominated by immunoassays. The market is restrained by various factors such as: success ratio of the researches is not very high, limitations of personalized medicines and lengthy regulatory approval process, reduction in funds by the US government, which owes 40% of this market, highly expensive medicines, which are 1000 fold costlier than the normal medicines present in the market and research and market is limited to a few developed nations only. Major opportunities for the market lie in the Asian markets where contract research organizations are on a rise. Proteomics is science with broad applications in the field of therapeutics and diagnostics. Growing R&D and emergence of new players will create more market opportunities. Major players in the proteomics market are Thermo Fischer scientific corporation, Agilent technologies, Luminex corporation, Sigma-Aldrich corporation, Danaher corporation, Bio-Rad corporation, Waters corporation, PerkinElmer, Affymetrix and others. Key Topics Covered: 1. Introduction 2. Market overview 3. Market determinants 4. Sector Analysis 5. Market Segmentation 6. Competitive Landscape 7. Geographical analysis 8. Company Profiles - Activx Biosciences Inc - Affymetrix - Agilent technologies - Amgen Inc - Anaspec Inc - Applied biosystems Inc - Asterand PLC - Bayer technology - Beckman coulter - Becton Dickinson and Co - BG medicine - Biacore International AB - Biocarta Inc - Bio-Rad corporation - Bruker biosciences - Caliper Lifesciences - Cellzome AG - Commonwealth biotechnologies - Danaher corporation - Digilab biovision GmBH - Dionex Corp - Dualsystems biotech AG - GE healthcare - Genesystems Inc - Genzyme Corporation - Luminex corporation - PerkinElmer - Sigma-Aldrich corporation - Thermo Fischer scientific corporation - Waters corporation For more information visit http://www.researchandmarkets.com/research/7f...proteomics
SIAL: 139.97 (+0.21), AMGN: 169.77 (-0.36), LMNX: 21.12 (+0.19), DHR: 81.19 (-0.25), BCOR: 10.72 (+0.26), PKI: 53.46 (+0.20), WAT: 156.19 (+0.09)
Illumina Set to Join the S&P 500
PR Newswire - Thu Nov 12, 5:44PM CST
Illumina Inc. (NASD:ILMN) will replace Sigma-Aldrich Corp. (NASD:SIAL) in the S&P 500 after the close of trading on Wednesday, November 18. Merck KGaA is acquiring Sigma-Aldrich in a deal expected to be completed on or about that date pending final conditions.
SIAL: 139.97 (+0.21), ILMN: 167.90 (-0.66), MHFI: 107.92 (+1.16)
Sigma-Aldrich's Buyout by Merck KGaA Gets Final EC Approval
Zacks Equity Research - Zacks Investment Research - Thu Nov 12, 11:00AM CST
Sigma-Aldrich (SIAL) has obtained the final clearance from the European Commission (???EC???) for its proposed acquisition Merck KGaA.
CE: 64.59 (+0.84), SIAL: 139.97 (+0.21), AVD: 16.75 (+0.18), CHMT: 30.27 (-0.03)
Sigma-Aldrich and Merck KGaA, Darmstadt, Germany, Obtain EC Antitrust Approval and Work Toward Closing Planned Acquisition
PR Newswire - Tue Nov 10, 10:52AM CST
Sigma-Aldrich Corporation (NASDAQ: SIAL) today announced it has secured final approval from the European Commission (EC) on the planned acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany.
HON: 116.39 (+0.26), SIAL: 139.97 (+0.21)
Sigma-Aldrich Shares Up 46.9% Since SmarTrend's Buy Recommendation (SIAL)
Comtex SmarTrend(R) - Thu Nov 05, 10:35AM CST
SmarTrend identified an Uptrend for Sigma-Aldrich (NASDAQ:SIAL) on April 2nd, 2014 at $95.00. In approximately 19 months, Sigma-Aldrich has returned 46.93% as of today's recent price of $139.58.
SIAL: 139.97 (+0.21)
47.0% Return Seen to Date on SmarTrend Sigma-Aldrich Call (SIAL)
Comtex SmarTrend(R) - Thu Nov 05, 10:31AM CST
SmarTrend identified an Uptrend for Sigma-Aldrich (NASDAQ:SIAL) on April 2nd, 2014 at $95.00. In approximately 19 months, Sigma-Aldrich has returned 46.97% as of today's recent price of $139.62.
SIAL: 139.97 (+0.21)
(0)
(0)Scroll down for more posts ▼